» Articles » PMID: 27489414

2016 Barriers to Cartilage Restoration

Overview
Specialty Orthopedics
Date 2016 Aug 5
PMID 27489414
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Cartilage restoration has flourished since the 1990s. The early pioneering work included cell therapy by Peterson, marrow stimulation by Johnson, osteochondral autograft treatments by Hangody, and osteochondral allografts by Gross. Since those early days, many scientists and clinicians have created "variations on a theme", markedly expanding the potential options for treating patients with symptomatic chondral lesions. Nevertheless, a variety of barriers exist between these new cartilage products and their clinical applications. These barriers may be categorized as cost, regulatory, insurance, and logistical issues. While absolute solutions will remain elusive, the current goal is to define these barriers as the first step toward solving these problems.

Citing Articles

Charting a quarter-century of commercial cartilage regeneration products.

Liu X, Guo X, Pei Y, Pei M, Ge Z J Orthop Translat. 2025; 50:354-363.

PMID: 39968336 PMC: 11833628. DOI: 10.1016/j.jot.2024.10.009.


Effects of glycosaminoglycan content in extracellular matrix of donor cartilage on the functional properties of osteochondral allografts evaluated by micro-CT non-destructive analysis.

Jin Y, Park D, Noh S, Kwon H, Shin D, Park J PLoS One. 2023; 18(5):e0285733.

PMID: 37220126 PMC: 10204946. DOI: 10.1371/journal.pone.0285733.


Surgical management of focal chondral defects of the knee: a Bayesian network meta-analysis.

Migliorini F, Eschweiler J, Schenker H, Baroncini A, Tingart M, Maffulli N J Orthop Surg Res. 2021; 16(1):543.

PMID: 34470628 PMC: 8409000. DOI: 10.1186/s13018-021-02684-z.


Larger Chondral Lesions Treated with Collagen Membrane - Matrix-Induced Autologous Chondrogenesis - Show Larger Increase in Clinical Scores.

Miyahira M, Novaretti J, Astur D, Kaleka C, Amaro J, Cohen M Rev Bras Ortop (Sao Paulo). 2021; 56(3):333-339.

PMID: 34239198 PMC: 8249057. DOI: 10.1055/s-0040-1712493.


Algorithm for Treatment of Focal Cartilage Defects of the Knee: Classic and New Procedures.

Hinckel B, Thomas D, Vellios E, Hancock K, Calcei J, Sherman S Cartilage. 2021; 13(1_suppl):473S-495S.

PMID: 33745340 PMC: 8808924. DOI: 10.1177/1947603521993219.


References
1.
Gross A, SILVERSTEIN E, Falk J, Falk R, Langer F . The allotransplantation of partial joints in the treatment of osteoarthritis of the knee. Clin Orthop Relat Res. 1975; (108):7-14. DOI: 10.1097/00003086-197505000-00003. View

2.
Steadman J, Rodkey W, Rodrigo J . Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res. 2001; (391 Suppl):S362-9. DOI: 10.1097/00003086-200110001-00033. View

3.
Lindahl A, Brittberg M, Peterson L . Health economics benefits following autologous chondrocyte transplantation for patients with focal chondral lesions of the knee. Knee Surg Sports Traumatol Arthrosc. 2001; 9(6):358-63. DOI: 10.1007/s001670100209. View

4.
Clar C, Cummins E, McIntyre L, Thomas S, Lamb J, Bain L . Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation. Health Technol Assess. 2005; 9(47):iii-iv, ix-x, 1-82. DOI: 10.3310/hta9470. View

5.
Kreuz P, Steinwachs M, Erggelet C, Krause S, Konrad G, Uhl M . Results after microfracture of full-thickness chondral defects in different compartments in the knee. Osteoarthritis Cartilage. 2006; 14(11):1119-25. DOI: 10.1016/j.joca.2006.05.003. View